ThermoGenesis Announces Expanded Collaboration With Celling Technologies
... of SpineSmith, LLC, related to the Company's bone marrow
products, MXP(TM) MarrowXpress(TM) ("MXP") and ... facilitates cryopreservation of processed bone marrow
aspirates. The bone marrow
concentrates are used in spinal fusion ....
ThermoGenesis Provides Update on Fiscal 2009 Results
... a point of care processing device for bone marrow
aspirate to concentrate stem cells, was formally launched in July. The Res-Q System processes bone marrow
in minutes and delivers a high rate of stem cell ... the market adoption of the Company's bone marrow
processing technologies and increase Company ...
Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress
... cells but permitted the regrowth of normal bone marrow
cells within 42 days of treatment in a Rag2-M ... up in higher levels by leukemic cells in the bone marrow
than by normal bone marrow
cells. They concluded that the preferential ...
Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
... ATIR(TM) showing its potential
in mismatched bone marrow
transplantations. Data was presented by ... Symposium at the Annual European Bone marrow
meeting (EBMT) in Goteborg, ... for early immune reconstitution following a
transplantation with a fully mismatched ...
ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
... the efficiency of stem cell recovery from bone marrow
following processing with the MXP and ... reduce and harvest stem cells from human bone marrow
in a functionally closed system.
Results ... efficient collection of stem cells from bone marrow
aspirate and platelet rich plasma from whole ...
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
... and Oncology. He began his training in bone marrow
transplantation while in medical school, with ... Miami , focused on pediatric immunology and bone marrow
transplantation. His research focus was in the ... with a clinical appointment on the Pediatric Bone marrow
Transplant Service at the University of ...
Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
... HIV infection and leukemia and received a bone marrow
transplant from a donor carrying the CCR5 mutation. After the successful bone marrow
transplant, HIV treatment was discontinued and ... occurring mutations in man and the recent bone marrow
transplant report," commented Dale Ando, M.D., ...
Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
... cell based therapeutics in
the field of bone marrow
transplantation, announces today the appointment ... Dr. Egeler is a global
leading pediatric bone marrow
transplantation physician and ... as Head
of the Pediatric Oncology and Bone marrow
Transplantation division of the
University of ...
Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
... enabling the use of a mismatched donor in a bone marrow
preventing acute Graft versus ... who is a leader in the field of mismatched
transplantations," says Dr. Manja Bouman, CEO of ... safe and potentially life-saving
mismatched bone marrow
transplantations as a treatment option for ...
StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
... and other
physicians specializing in bone marrow
"We are excited to develop ... to provide a new
device to facilitate bone marrow
harvest, with the goal of improving the
donor ... is designed to rapidly and easily harvest
in a minimally invasive manner, in the outpatient ...
High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma
... an innovative study that investigated
high (bone marrow
ablative) dose Zevalin(R) ([90Y]-ibritumomab ... were noted with this
regimen. The expected severe marrow
suppression associated with
myeloablative ... toxicity correlated with the degree of
involvement prior to Zevalin therapy. ...
CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
... President of the European Group of Bone marrow
(EBMT). During her 30 years as a ... Dr. Gluckman has performed
over 1,900 bone marrow
and cord blood transplants.
"I am very honored ... Levine was responsible for initiating the
and umbilical cord blood research programs at the ...
Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
... N.J., Oct. 2 /PRNewswire/ -- The Blood and marrow
Transplantation Program at the John ... and
healthcare organizations. The Blood and marrow
Transplantation Program also
recently became the ... high level of expertise offered by
our Blood and marrow
Stem Cell Transplantation Program's chief, Dr. ...
Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
... therapy and, infrequently, bone marrow
-- a procedure that carries ... nocturnal hemoglobinuria-type cells in bone marrow
syndrome. Blood 2002;100:3897-3902.
(7) ... (8) Maciejewski, et al. Relationship between bone marrow
syndromes and the presence of ...
Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants
... Researchers and
clinicians at the Adult Blood and marrow
Stem Cell Transplantation Program
at The Cancer ... A New Paradigm for Designer
Allogeneic Blood and marrow
Transplantation," was co-authored by ... L.
Donato, M.D., director of the Blood and marrow
Collection Facility; and
Scott D. Rowley, M.D., ...
Repair Stem Cell Institute Announces Science Advisory Board
... Professor Shimon Slavin, M.D., an expert bone marrow
scientist and clinician, is ... stem cells) taken from their bone marrow
and multiplied in culture.
Dr. Slavin is the ... in
RSC treatments, rejected traditional bone marrow
stem cells as a too
limited source for the ...
ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
... APPLICATION WILL BE FOR USE IN POINT-OF-CARE BONE marrow
RANCHO CORDOVA, Calif., July 14 ... William Osgood, Chief Executive Officer.
derived stem cells are the dominant source of ... than twice these amounts.
In addition, bone marrow
stem cells are currently processed in a number
Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
... intracellular uptake of LOR-2040 in
the bone marrow
leukemic cells, and identified significant accumulation of
the drug in the bone marrow
blast cells and suggested preferential uptake
of ... drug by CD34+ cells, an important malignant bone marrow
The authors concluded that ...
Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
... In addition, within a subgroup in
which bone marrow
cells were examined before and after treatment, ... also showed the greatest increase in
stem cells. The trial was conducted by principal ... responders had the
largest fold increase in bone marrow
stem cells twelve days after dosing.
StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform
... stem and progenitor
cells it contains, for bone marrow
transplantation. Additionally," he
explained, ... to rapidly and easily
harvest stem cell-rich bone marrow
in a minimally-invasive manner, in the
outpatient ... is in contrast to
the current practice of bone marrow
aspiration through the insertion of a
large gauge ...
ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
... AND STORAGE OF EQUINE CORD BLOOD, BONE marrow
AND PLACENTAL TISSUE STEM CELLS
RANCHO CORDOVA, ... of stem cells from equine
cord blood, bone marrow
and placental tissue. These cells will be used ... of bacterial-induced alterations in bone marrow
proliferation and differentiation. She has ...
CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
... Division of Hematology-
Oncology and Blood and marrow
Transplantation at the University of
Minnesota. ... is the
Director of the Pediatric Blood and marrow
Program at Duke University and
the Medical ... Levine was responsible
for initiating the bone marrow
and umbilical cord blood research programs
at the ...
Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
... of cancer cells from an autologous graft in
transplantations for end-stage blood cancer ... improved overall survival after
autologous bone marrow
transplantation in Non-Hodgkin's lymphoma ... autologous transplant uses the patient's own bone marrow
to serve as a
graft. Bone-marrow transplants are ...
Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
... material. The addition of
autologous bone marrow
further enhances the bone forming capability of ... material that is hydrated
with autologous bone marrow
at the point of use. OssiMend strips and pads
can ... OssiMend, we are introducing a Multi-port Bone marrow
Needle to aid in the harvest of ...
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
... therapy and, infrequently, bone marrow
-- a procedure that carries ... nocturnal hemoglobinuria-type cells in bone marrow
failure syndrome. Blood 2002;100:3897-3902. ... Maciejewski, et al. Relationship between bone marrow
failure syndromes and the presence of ...
RSCI Announces World-Leading Stem Cell Science Advisory Board
Professor Shimon Slavin, M.D., Deputy Chairman, is an expert bone marrow
transplantation scientist and clinician, is famous for his innovative ... experts in stem cell treatments, rejected traditional bone marrow
stem cells as a too-limited source for the neurological stem cells ...
Lilly Set to Unveil More Than 50 Studies at ASCO 2009
... of side effects associated with ALIMTA therapy. ALIMTA can suppress bone marrow
function. It is very important to take folic acid and vitamin B12 prior to ... tell your doctor you should not receive it. GEMZAR can suppress bone marrow
function. There have been rare reports of serious kidney or liver toxicity ...
Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies
Amniotic fluid (AF) cells that had markers similar to bone marrow
stem cells (termed AFKL cells) were then isolated for use in experiments, ... ability of the transplanted cells to produce new blood cells.
samples from the transplanted mice were also taken and injected in a ...
Renowned Stem Cell Researcher Files Study Results With Stemedica
... long term safety of adult stem cells in general and our mesenchymal bone marrow
stem cell line in particular. Secondarily, study results clearly showcase ... osteonecrosis in relation to sickle cell disease to the use of bone marrow
grafts in the treatment of delayed unions and non unions. Dr. Hernigou ...
International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
... serum FLC measurements reduce the
need for frequent, painful bone marrow
- for some intact immunoglobulin MM patients in remission,
... a condition known as
myeloma. Myeloma cells gradually replace healthy bone marrow
to bone pain and infections. A patient with myeloma may ...
Transplant Program Tops in Expected One-Year Survival Rate
... over a five-year
The Center for International Blood and marrow
Transplant Registry examined
the survival rates of 8,847 transplants performed to treat blood cancers at
U.S. centers in the National marrow
Donor Program (NMDP) network. The
survival data was collected for the ...
Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
... non-specific immunosuppressive
therapy and, infrequently, bone marrow
transplantations -- a procedure that
carries considerable mortality risk. ... Maciejewski JP, Risitano AM, Sloand EM, et al. Relationship between
failure syndromes and the presence of glycophosphatidyl inositol-
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
... of side effects associated with ALIMTA therapy. ALIMTA can
suppress bone marrow
function. It is very important to take folic acid and
vitamin B12 prior to ... tell your doctor you should not receive it. GEMZAR can suppress
function. There have been rare reports of serious kidney or
liver toxicity ...
ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
... device in the U.S. The MXP is used for
concentrating stem cells from bone marrow
at both the point-of-care and in
a laboratory setting.
"In addition, we ... that will offer stem cell laboratory services and point-of-care bone marrow
and peripheral blood processing products focused initially on the ...
Sangamo BioSciences Reports Second Quarter 2008 Financial Results
... in the peripheral blood. In addition, within a
subgroup in which bone marrow
cells were examined before and after
treatment, the data suggests that ... the tissues of the lower
limbs, also showed the greatest increase in bone marrow
stem cells. This
observation of stem cell mobilization after treatment ...
ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
... product in the European Community. The MXP device is
used to process bone marrow
in a laboratory setting.
The MXP is a derivative of the Company's ... very encouraging feedback from a number of European
centers at which bone marrow
clinical trials are either underway or
planned. With this approval, we can ...
Genzyme Files Applications for Approval of Mozobil in the United States and Europe
... Clinical Role
Mozobil is designed to mobilize stem cells from the bone marrow
the bloodstream where they can be collected, making it more likely ... marrow. A stem cell transplant is required to replenish
blood-forming bone marrow
cells destroyed by high-dose chemotherapy. Stem
cells differentiate into ...
Israeli Scientists Recipients of 2008 International Adult Stem Cell Award
... Margolis, WCASCE Chairman and Founder, "Professor
Slavin is an expert bone marrow
transplantation scientist and clinician.
The former Director of Israel's ... of adult stem cells (mesenchymal stromal stem cells) taken
from their bone marrow
and multiplied in culture. Some of the patients'
conditions have improved ...
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
demineralized bone matrix (DBM) and viable MSCs native to the marrow
bone. Found in human bone marrow, MSCs are fundamental regenerative ... tissue. MSCs are believed to help regulate the behavior
of other bone marrow
Alex Lukianov, Chairman and Chief Executive Officer, said, ...
JCI online early table of contents: March 6, 2008
... mutations in the SBDS gene and characterized by, among other things, bone marrow
failure and an increased risk of acute myeloid leukemia. New insight into ... Boston and the University of Washington, Seattle, who analyzed human bone marrow
stromal cells (BMSCs) and skin fibroblasts.
In BMSCs from healthy ...